1Lower F,Robertsion C,Roehrborn C,et al.Meta-analysis of clinical trials of permixon[J]. J Urol,1998,159 (Suppl 5) : 616.
2Lowe F C,McConnell J D,Hudson P B,et al.Long-term 6-year expe-rience with finasteride in patients with benign prostatic hyperplasia[J]. Urology, 2003 ,61(4):791-796.
3Lynch T H. Doxazosin and finasteride alone or in combination: the PREDICT study[J]. BJU Int, 2003 ,91(7):591-592.
4Athanasopoulos A, Gyttopoulos K, giannitsask,et al.Combination tr-eatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective,randomized,controlled study[J]. J Urol, 2003,169(6):2253-2256.
5DeNunzio C,Franco G,Iori F,et al.Clinical and pressure-flow chan-ges after long-term treatment with alfuzosin SR[J]. Urol Int,2003,71(1):31-36.
6Kirby R S. Terazosin in benign prostatic hyperplasia: effects on blood pressure in norniotensive and hypertensive men[J]. Br J Urol,1998,82(3):373-379.
7Akaska T,Funaki H,Hirano S,et al.Long-term efficacy of naftopidit for treatment of lower uriary tract symptoms with benign prostatic hyperplasia[J]. Hinyoka Kiyo,2003,49(4): 189-193.
8Choo M S,Bellamy F,Constantinocl C E. Functional evaluation of tadenan on micturition and experimental piostate growth incluced with exogenous dihydrotestosterone[J]. Urology,2000,55(2):292-298.
9McConnell J D. BPH: hormonal treatment[J]. Urol Clin North Am,1995,22(3):387-390.
